Everest Acquisition Everest Clinical Research acquired August Research, creating a channel to Everest’s sponsor network and opening cross-sell opportunities for regulatory, pharmacovigilance, and site-management services across Europe. August’s deep Central and Eastern Europe expertise could help Everest expand its European footprint and service coverage.

European Trial Strength The company combines deep Central and Eastern Europe know-how with a high-touch approach to site management, leading to better quality and faster enrollment for Phase I through IV trials. This positions August as a compelling partner for sponsors seeking efficient European trial execution.

Full Service CRO Offers end-to-end clinical operations and pharmacovigilance services, including regulatory submissions, study start-up, site contracting, monitoring, project management, and quality assurance/audits. PV services include safety plans, database management, case entry, and reporting, enabling a one-stop European solution for sponsors.

Mid-Size Biotech Ideal clients are mid-sized biotech and pharma sponsors needing Phase I to IV trials across Europe, with a preference for high-quality enrollment and tight site management. The profile suggests a fit for sponsors expanding into Europe or seeking a reliable European CRO with local expertise.

Growth Through Integration The acquisition hints at growth capacity via Everest resources, enabling scale for larger studies and broader service lines, including expanded PV and regulatory offerings. This could unlock opportunities to pitch comprehensive Europe-wide trial programs to global sponsors.